HPMA - docetaxel or gemcitabine conjugates and uses therefore

Details for Australian Patent Application No. 2009302387 (hide)

Owner University of Maryland, Baltimore Rexahn Pharmaceuticals, Inc

Inventors Lee, Young Bok; Ahn, Chang Ho; Kim, Deog Joong; Ghandehari, Hamidreza; Ray, Abhijit; Nan, Anjan

Agent Fisher Adams Kelly

Pub. Number AU-A-2009302387

PCT Pub. Number WO2010/042638

Priority 61/103,390 07.10.08 US

Filing date 7 October 2009

Wipo publication date 15 April 2010

International Classifications

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

19 May 2011 PCT application entered the National Phase

  PCT publication WO2010/042638 Priority application(s): WO2010/042638

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009302408-System and method for transporting energy

2009302385-Telomerase inhibitors and methods of use thereof